You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Self-monitoring of blood glucose was not cost-effective in non–insulin-treated type 2 diabetes

https://doi.org/10.1136/ebm.13.6.171

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    J Simon

    Dr J Simon, University of Oxford, Oxford, UK; judit.simon@dphpc.ox.ac.uk

    STUDY DESIGN

    Design:

    cost-effectiveness analysis of a randomised controlled trial with 1-year follow-up (Diabetes Glycaemic Education and Monitoring [DiGEM]).

    STUDY QUESTION

    Setting:

    48 general practices in the UK.

    Patients:

    453 patients {mean age 66 y, 57% men}* who had non–insulin-treated type 2 diabetes with haemoglobin (Hb) A1c concentrations ⩾6.2% and were not self-monitoring glucose. {Exclusion criteria included serious …

    View Full Text

    Footnotes

    • Source of funding: UK NHS and NHS Health Technology Assessment Programme.